Reversal of vanadate inhibition of NaK-ATPase by catecholamines.
D001205:Ascorbic Acid / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology*; D002396:Catechols / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D003634:DDT / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000201:enzymology; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*; D014639:Vanadium / Q000037:antagonists & inhibitors*
D002395:Catecholamines; D002396:Catechols; D014639:Vanadium; D003634:DDT; D000254:Sodium-Potassium-Exchanging ATPase; D003545:Cysteine; D007545:Isoproterenol; D001205:Ascorbic Acid